Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/FCF ratio high or low?
The Price/FCF ratio of 7.86 is in line with its 1-year average of 7.74, around the middle of its 1-year range (7.48–8.06).
As of Thursday, August 27, 2026.
PRICE/FCF RATIO
7.86
PRICE/FCF RATIO AVG TTM
N/A
PRICE/FCF RATIO AVG 3Y
N/A
PRICE/FCF RATIO AVG 5Y
N/A
PRICE/FCF RATIO AVG 10Y
N/A
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
22.38
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-64.88%
vs the sector median at left
Market Cap
$104.87B
Price/FCF Ratio
17.16
TTM Avg
15.76
3Y Avg
20.38
5Y Avg
16.79
Market Cap
$90.56B
Price/FCF Ratio
15.58
TTM Avg
13.81
3Y Avg
15.77
5Y Avg
20.32
Market Cap
$125.43B
Price/FCF Ratio
26.44
TTM Avg
31.58
3Y Avg
39.92
5Y Avg
40.28
Market Cap
$86.04B
Price/FCF Ratio
13.83
TTM Avg
17.25
3Y Avg
41.49
5Y Avg
30.23
Market Cap
$131.04B
Price/FCF Ratio
40.83
TTM Avg
69.69
3Y Avg
158.93
5Y Avg
125.93
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanofi (SNY) | $107.47B | 7.86 | N/A | N/A | N/A |
| McKesson Corporation (MCK)vs › | $104.87B | 17.16 | 15.76 | 20.38 | 16.79 |
| GSK plc (GSK)vs › | $100.54B | 10.94 | 12.96 | 13.85 | 12.23 |
| Medtronic plc (MDT)vs › | $116.60B | 21.36 | 21.91 | 22.19 | 23.05 |
| CVS Health Corp. (CVS)vs › | $119.16B | 10.14 | 15.85 | 14.99 | 12.06 |
| HCA Healthcare, Inc. (HCA)vs › | $90.56B | 15.58 | 13.81 | 15.77 | 20.32 |
| Stryker Corporation (SYK)vs › | $125.43B | 26.44 | 31.58 | 39.92 | 40.28 |
| Elevance Health Inc. (ELV)vs › | $86.04B | 13.83 | 17.25 | 41.49 | 30.23 |
| Intuitive Surgical, Inc. (ISRG)vs › | $131.04B | 40.83 | 69.69 | 158.93 | 125.93 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.51B | 24.49 | 18.69 | 23.34 | 20.95 |
P/FCF Ratio
7.9
FCF Yield
12.72%
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-08-27 | 7.86 |
| 2026-08-26 | 7.96 |
| 2026-08-25 | 8.06 |
| 2026-08-24 | 8.01 |
| 2026-08-21 | 8.03 |
| 2026-08-20 | 7.91 |
| 2026-08-19 | 8.03 |
| 2026-08-18 | 7.88 |
| 2026-08-17 | 7.78 |
| 2026-08-14 | 7.66 |
| 2026-08-13 | 7.67 |
| 2026-08-12 | 7.66 |
| 2026-08-11 | 7.63 |
| 2026-08-10 | 7.62 |
| 2026-08-07 | 7.61 |
| 2026-08-06 | 7.51 |
| 2026-08-05 | 7.50 |
| 2026-08-04 | 7.48 |
| 2026-08-03 | 7.53 |
| 2026-07-31 | 7.55 |
| 2026-07-30 | 7.51 |
